Brief: Solid Biosciences Announces FDA IND Clearance for First-In-Industry Dual Route of Administration Gene Therapy to Treat Both Neurologic and Cardiac Manifestations of Friedreich’s Ataxia

Solid Biosciences

07/01/2025 21:23

Jan 7 (Reuters) - Solid Biosciences Inc  SLDB.O :
    * SOLID BIOSCIENCES ANNOUNCES FDA IND CLEARANCE FOR
FIRST-IN-INDUSTRY DUAL ROUTE OF ADMINISTRATION GENE THERAPY TO
TREAT BOTH NEUROLOGIC AND CARDIAC MANIFESTATIONS OF FRIEDREICH’S
ATAXIA
    * SOLID BIOSCIENCES INC: PHASE 1B CLINICAL TRIAL INITIATION
EXPECTED IN 2H 2025

Source text:  ID:nGNXbQwqFD 
Further company coverage:  SLDB.O 

 ((Reuters.Briefs@thomsonreuters.com;))